课题基金 / 基金详情

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema
评估。
批准号:
8339807
负责人:
Frederick Ferris
金额:
$16.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Frederick Ferris的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明视网膜小胶质细胞确实与糖尿病视网膜病变有关。二甲胺四环素是第二代四环素,它具有抗炎特性,与抗菌特性分开。研究目的是探讨米诺环素(一种小胶质细胞抑制剂)治疗糖尿病性黄斑水肿的安全性和有效性。这是一项前瞻性、非随机、非控制、单组、单中心的试点研究,旨在研究二甲醚患者使用米诺环素作为小胶质细胞抑制剂的安全性和有效性,这些患者已经接受了标准护理激光治疗或不适合标准护理治疗。
英文摘要
There is accumulating evidence that retinal microglia are indeed associated with diabetic retinopathy. Minocycline is a second-generation tetracycline, which has anti-inflammatory properties that are separate from its anti-microbial properties. The study objective is to investigate the safety and efficacy of minocycline, a microglia inhibitor, in the treatment of diabetic macular edema. This is a prospective, non-randomized, uncontrolled, single group, singlecenter pilot study to investigate the safety and efficacy of minocycline as a microglia inhibitor in patients with DME who have already been treated with standard-of-care laser or who are not amenable to standard-of-care therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SNPs in Patients with and without Diabetic Macular Edema
  • 批准号:
    8556861
  • 项目类别:
  • 资助金额:
    $9.98万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
Internal Monitoring of Eye Movement in Schizophrenia
  • 批准号:
    8737660
  • 项目类别:
  • 资助金额:
    $2.36万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,
  • 批准号:
    8339806
  • 项目类别:
  • 资助金额:
    $28.52万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
Internal Monitoring of Eye Movement in Schizophrenia
  • 批准号:
    8339804
  • 项目类别:
  • 资助金额:
    $3.28万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
海外基金